This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Technical Scrutiny: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, And Raptor Pharma Corp.

LONDON, September 19, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Wednesday, September 18, 2013, the Dow Jones Industrial Average, the S&P 500 and the NASDAQ Composite finished the day 0.95%, 1.22% and 1.01% higher, respectively. Shares in the major drug manufacturer companies ended mostly on a higher note as the broader market posted gains. The major movers included GlaxoSmithKline PLC (NYSE: GSK), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), AstraZeneca PLC (NYSE: AZN), and Raptor Pharmaceutical Corporation (NASDAQ: RPTP). AAAResearchReports.com has tracked GSK, KERX, AZN, and RPTP. These reports can be seen for free at:

http://www.aaaresearchreports.com/register/  

On Wednesday, GlaxoSmithKline PLC's stock advanced to close at $51.27, up 0.27% from the previous day's closing price of $51.13. The company's shares oscillated between $50.53 and $51.40 during the trading session. A total of 2.41 million shares were traded, which is above the daily average volume of 2.08 million. The company's shares have lost 0.27% in the previous three trading sessions, compared to a gain of 2.22% in the S&P 500 during the same period. Further, GlaxoSmithKline PLC's stock is trading above its 200-day moving average of $48.53. Download free research on GSK by signing up now at:

http://www.AAAResearchReports.com/GSK091913.pdf

Shares in Keryx Biopharmaceuticals Inc. fell sharply on Wednesday, even as the broader market posted significant gains. The company's shares fluctuated between $9.56 and $9.93 before closing the day 1.00% lower at $9.90. A total of 2.94 million shares were traded, which is more than the daily average volume of 1.92 million. Despite Wednesday's pullback, the company's shares have rallied 18.14% in the previous one month and 29.24% in the last three months, outperforming the S&P 500 which has gained 4.21% and 4.46% during the respective periods.  Moreover, Keryx Biopharmaceuticals Inc.'s stock has moved closer to its 52-week high of $10.04 as well as above its 50-day and 200-day moving averages of $8.82 and $6.97, respectively. Register for today's free analysis on KERX at:

http://www.AAAResearchReports.com/KERX091913.pdf

On Wednesday, AstraZeneca PLC's shares rose sharply by 1.58%, tracking gains in the US equity market. The company's shares finished the day at $52.08 after fluctuating between $51.22 and $52.13 during the trading session. A total of 1.36 million shares were traded, which is below the daily average volume of 1.68 million. The company's stock has gained 2.82% in the previous three trading sessions and 4.18% in the last one month, outperforming the S&P 500 which has gained 2.22% and 4.21% during the respective periods. Additionally, AstraZeneca PLC's shares are trading above their 50-day 200-day moving averages of $50.16 and $49.27, respectively. A free report on AZN can be accessed by registering at:

http://www.AAAResearchReports.com/AZN091913.pdf

Shares in Raptor Pharmaceutical Corp. edged higher on Wednesday, extending the gains from the previous trading session. The company's shares finished the day 0.35% higher at $14.35 after fluctuating between $14.04 and $14.42 during the trading session. A total of 0.60 million shares were traded, which is below the daily average volume of 0.72 million. The company's shares have rallied 83.27% in the previous three months and 25.88% in the last one month, outperforming the S&P 500 which has advanced 4.46% and 4.21% during the respective periods. Further, Raptor Pharmaceutical Corp.'s stock is trading close to its 52-week high of $14.90 as well as above its 50-day and 200-day moving averages of $11.80 and $7.57, respectively. Register with AAA Research Reports and download research on RPTP for free at:

http://www.AAAResearchReports.com/RPTP091913.pdf

----

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs